Cn /En

News Center

——

Company news

Industry news

Advantages of the InnoModels Biotechnology Inflammatory Bowel Disease (IBD) Model

Author:

InnoModels

Release time:

2024-09-12

Inflammatory Bowel Disease (IBD) is a group of complex, recurrent inflammatory diseases of the intestines, mainly including Crohn's Disease (CD) and Ulcerative Colitis (UC). As the incidence of IBD rises, the study of its pathogenesis and therapeutics becomes particularly important. Modeling organisms, especially mouse models, play a key role in this field. In this paper, we will introduce the advantages of InnoModels Biotechnology IBD models in detail.
1、Model diversity and specificity
The IBD models of InnoModels have diversity and specificity, and can simulate different disease states according to different induction methods and mechanisms. The main models include chemical induction models (e.g., DSS, TNBS, etc.), spontaneous mutation models, overdose T-cell transfer models, gene editing models and microbial induction models.
1.1 Chemically induced models
Chemically induced models, especially the mouse IBD model induced by Dextran Sulfate Sodium (DSS), is one of the most widely used models.The DSS model induces pathological features similar to those of human ulcerative colitis by disrupting the intestinal barrier function, activating the immune system, and triggering oxidative stress ^[1][2][3]^.The advantages of the DSS model are that it is easy to operate, and it is easy to use. model has the advantage of simplicity, reproducibility, and short disease duration, and is able to simulate the acute or chronic pathological changes of IBD in a short period of time.
1.2 Spontaneous mutation models
Spontaneous mutation models, such as SAMP1/Yit and C3H/HeJBir mice, are capable of producing chronic intestinal inflammation due to naturally occurring mutations. These models have the advantage of being able to more realistically mimic the natural onset of human IBD, but their main limitation is the long time required for onset, e.g., the SAMP1/Yit strain has a 30-week onset cycle^[1]^.
1.3 Relay T-cell transfer models
The Transmissive T-cell transfer model mimics T-cell-driven IBD by transferring specific T-cell subsets (e.g., CD4+ T-cells) to recipient mice, causing chronic inflammation in the small intestine and colon.This model has the advantage of being able to study the role of specific T-cell subsets in the onset and progression of the disease ^[2][4]^.
1.4 Gene editing models
Gene editing models such as IL-10 knockout mice are able to naturally develop colitis or ileitis by introducing susceptibility genes through gene editing techniques. The advantage of these models is that they highly mimic the genetic background found in human IBD, but their disease development is highly dependent on the microbiome and the disease takes longer to develop^[1]^.
2. Rapid screening of potential therapeutic drugs
InnoModels Biotechnology IBD models play an important role in drug screening and therapeutic strategy development. By using these models, researchers are able to rapidly assess the efficacy and safety of drugs and accelerate the process of new drug development.
2.1 Application of DSS models in drug evaluation
DSS models are commonly used to assess the effects of anti-inflammatory drugs and immunomodulatory drugs. For example, in a DSS-induced acute IBD model, Cyclosporin A (CsA) was shown to significantly alleviate inflammatory bowel disease symptoms in mice with a dose-dependent effect^[2][3]^. This model enables rapid screening of potential therapeutic agents and provides strong support for clinical trials.
2.2 Application of the Transient T-cell Transfer Model in Drug Evaluation
The model of transitory T-cell transfer can be used to evaluate drugs targeting T cells. For example, drug efficacy assessment using anti-IL-12 antibody in the relays T-cell transfer model can investigate the mechanism of T-cell action in IBD and screen effective drugs targeting T-cell-driven IBD ^[2]^.

3. Promote understanding of disease mechanisms
InnoModels' IBD model not only helps drug screening, but also promotes the understanding of the pathogenesis of IBD. By simulating different disease stages and pathological features, researchers are able to delve into the immunopathological mechanisms of IBD and provide a theoretical basis for the development of new therapeutic strategies.
3.1 Research on Inflammatory Mechanisms
The DSS model induces an inflammatory response similar to human IBD by disrupting the intestinal barrier function and activating the innate and adaptive immune systems. Researchers can use this model to study the mechanisms of inflammatory cytokine release, immune cell infiltration and repair of the intestinal mucosal barrier^[2]^.
3.2 Research on genetic background
Gene editing models such as IL-10 knockout mice provide an important tool for studying the genetic background of IBD by mimicking susceptibility genes in human IBD. These models help to reveal the role of specific genes in the pathogenesis of IBD and provide a basis for genetic counseling and personalized treatment^[1]^.
4 Conclusion.
The IBD models of InnoModels Biotechnology have played an important role in the study of IBD pathogenesis, drug screening and development of therapeutic strategies. With the advantages of diversity, specificity and operability, these models can rapidly simulate the pathological features of human IBD and provide powerful support for new drug development and disease treatment. With the continuous advancement of technology and the continuous optimization of models, the IBD models of InnoModels Biotechnology will play an even more important role in the field of IBD research.
References
1. Katsandegwaza B, Horsnell W, Smith K. Inflammatory Bowel Disease: a Review of Pre-Clinical Murine

InnoModels Biotechnology qPCR Platform

Features of the Luminex platform from InnoModels Biotechnology

InnoModels Biotechnology qPCR Platform

Features of the Luminex platform from InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License